Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%

Bulletin Express

06/10

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).

The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.

Following the transaction: • Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%. • Treasury shares rose from 8.03 million to 8.04 million. • Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.

The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1143399343"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143399343\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143399343?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143399343","market":"hk","top_or_hot":-1,"title":"Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Repurchases 10,000 A Shares for ESOP, Outstanding Float Falls 0.0002%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-10 17:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).</p>\n<p>The repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.</p>\n<p>Following the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.</p>\n<p>The company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞醫藥","start_time":0,"source_url":"","article_id":"1143399343","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143399343","pubTimestamp":1781084569,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药回购1万股A股用于ESOP流通股跌0.0002%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma; HKEX: 01276) disclosed on 10 June 2026 that it bought back 10,000 A shares on the Shanghai Stock Exchange for its A-share Employee Stock Ownership Schemes (ESOP).\nThe repurchase was executed on 10 June 2026 at prices between RMB 46.02 and RMB 46.06 per share, translating into a volume-weighted average cost of RMB 46.04 and a total consideration of RMB 0.46 million.\nFollowing the transaction:\n• Issued shares in public hands (excluding treasury shares) declined from 6,370.97 million to 6,370.96 million, a reduction of 0.0002%.  \n• Treasury shares rose from 8.03 million to 8.04 million.  \n• Total issued share capital remained unchanged at 6,379.00 million shares, as the repurchased stock is held in treasury and not yet cancelled.\nThe company confirmed that the repurchase was duly authorised, executed in compliance with all applicable regulations and stock-exchange rules, and that full payment for the shares has been settled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}